Lacutamab (Anti-KIR3DL2 / CD158k)

Ask supplier a question | View on supplier's website

Lacutamab (Anti-KIR3DL2 / CD158k) is a humanized monoclonal antibody against the immune receptor human killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 2 (KIR3DL2), with potential immunomodulating and antineoplastic activities. MW: 150 kD.

Supplier	Selleck Chemicals
Product #	A2418
Sku #	A2418-1mg
Pricing	1mg, $370.00

Feedback